Unitedhealth Story

<div class='circular--portrait' style='background:#FF0F00;color: #FFFFF0;font-size:5em;'>U</div>
UNH -- USA Stock  

USD 332.20  3.33  1.01%

The predictive indicators we use to evaluate UnitedHealth help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of UnitedHealth Group Incorporated. We apply different methods to arrive at the intrinsic value of UnitedHealth based on widely used predictive technical indicators. Today's article will concentrate on UnitedHealth Group. Why are we still confident in our hopes for a recovery.
Published over a month ago
View all stories for Unitedhealth | View All Stories
Will UnitedHealth Group (NYSE:UNH) continue to rise?
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. UnitedHealth Group has an asset utilization ratio of 227.03 percent. This implies that the company is making $2.27 for each dollar of assets. An increasing asset utilization means that UnitedHealth Group Incorporated is more efficient with each dollar of assets it utilizes for everyday operations. Earning per share calculations of UnitedHealth Group is based on official Zacks consensus of 7 analysts regarding UnitedHealth Group's future annual earnings. Given the historical accuracy of 96.71%, the future earnings per share of the company is estimated to be 16.7525 with the lowest and highest values of 16.73 and 16.79, respectively. Please note that this consensus of annual earnings estimates for the firm is an estimate of EPS before non-recurring items and including employee stock options expenses.
The successful prediction of Unitedhealth stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Unitedhealth Group, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Unitedhealth based on Unitedhealth hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Unitedhealth's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Unitedhealth's related companies.

Use Technical Analysis to project Unitedhealth expected Price

Unitedhealth technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Unitedhealth technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Unitedhealth trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

What do experts say?

Stock analysis is a method for investors and traders to make buying and selling decisions. By studying and evaluating past and current data, investors and traders attempt to gain an edge in the markets by making informed decisions.
It is good to see analyst projects for Unitedhealth, but it might be worth checking our own buy vs. sell analysis

Acquisition by Lewis Patricia L of 13390 shares of Unitedhealth subject to Rule 16b-3

Legal trades by Unitedhealth insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:
Unitedhealth insider trading alert for grant of non-qualified stock option (right to buy) by Lewis Patricia L, EVP and Chief HR Officer, on 24th of February 2021. This event was filed by Unitedhealth Group Inc with SEC on 2021-02-24. Statement of changes in beneficial ownership - SEC Form 4 [view details]   
Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

What is driving Unitedhealth Investor Appetite?

The modest gains experienced by current holders of UnitedHealth Group created some momentum for stockholders as it was traded today as low as 351.56 and as high as 356.96 per share. The company directors and management have been quite successful in maneuvering the stock at opportune times to take advantage of all market conditions in December. The stock standard deviation of daily returns for 30 days investing horizon is currently 1.88. The below-average Stock volatility is a good sign for longer-term investment options and for buy-and-hold investors.

Deferred Revenue Breakdown

UnitedHealth Group Deferred Revenue is increasing over the last several years with slightly volatile swings. Deferred Revenue is predicted to flatten to about 1.5 B. Deferred Revenue usually refers to a component of Total Liabilities representing the carrying amount of consideration received or receivable on potential earnings that were not recognized as revenue; including sales; license fees; and royalties; but excluding interest income. UnitedHealth Group Deferred Revenue is most likely to increase significantly in the upcoming years. The last year's value of Deferred Revenue was reported at 1.77 Billion
20111.23 Billion
20121.5 Billion
20131.6 Billion
20141.97 Billion
20152.14 Billion
20161.97 Billion
20201.77 Billion
20211.48 Billion

Will UnitedHealth continue to rise?

Current downside deviation is at 1.3. UnitedHealth Group Incorporated has relatively low volatility with skewness of 2.64 and kurtosis of 13.99. However, we advise all investors to independently investigate UnitedHealth Group Incorporated to ensure all accessible information is consistent with the expectations about its upside potential and future expected returns.

The Current Takeaway on UnitedHealth Group Investment

While other entities under the healthcare plans industry are still a bit expensive, UnitedHealth Group may offer a potential longer-term growth to stockholders. While some stockholders may not share our view we believe that the current risk-reward utility is not appealing enough to do any trading. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to UnitedHealth Group.

About Contributor

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Gabriel Shpitalnik do not own shares of Unitedhealth Group. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com